Complex Innovative Design for Liver Disease Clinical Trials
1. Abstract In recent years, the prevalence of liver diseases such as hepatitis B (or C) virus infection (HBV or HCV), non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have received much attention world-wide. DOI:http://dx.doi.org/10.47829/JJGH.2021.7402